It is well-known that STAT3 and to some extent STAT1 is activated in breast cancers and that constitutively active mutants of STAT3 promote the growth and survival of tumor cells thereby contributing to malignancy [13-15]. This evidence concerns the gene STAT1 and neoplasm.